XRTX
NASDAQ · Pharmaceuticals
Xortx Therapeutics Inc
$2.65
-0.11 (-3.99%)
Open$2.70
Previous Close$2.76
Day High$2.86
Day Low$2.60
52W High$9.85
52W Low$2.42
Volume—
Avg Volume7.0K
Market Cap5.43M
P/E Ratio—
EPS$-2.25
SectorPharmaceuticals
Analyst Ratings
Strong Buy
5 analysts
Price Target
+1,509.1% upside
Current
$2.65
$2.65
Target
$42.64
$42.64
$28.32
$42.64 avg
$47.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 60.77M | 76.14M | 1.25M |
| Net Income | -5,748,575 | -6,482,542 | 338.7K |
| Profit Margin | -2.6% | -2.5% | 27.0% |
| EBITDA | -6,807,631 | -8,103,307 | 499.5K |
| Free Cash Flow | — | — | 161.5K |
| Rev Growth | -20.2% | -20.2% | +20.7% |
| Debt/Equity | 0.02 | 0.02 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |